Last reviewed · How we verify
Cord Blood Infusion — Competitive Intelligence Brief
phase 2
Hematology
Biologic
Live · refreshed every 30 min
Target snapshot
Cord Blood Infusion (Cord Blood Infusion) — Joanne Kurtzberg, MD. Cord blood infusion involves the transfer of hematopoietic stem cells from the umbilical cord to a recipient to stimulate the production of new blood cells.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Cord Blood Infusion TARGET | Cord Blood Infusion | Joanne Kurtzberg, MD | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Cord Blood Infusion CI watch — RSS
- Cord Blood Infusion CI watch — Atom
- Cord Blood Infusion CI watch — JSON
- Cord Blood Infusion alone — RSS
Cite this brief
Drug Landscape (2026). Cord Blood Infusion — Competitive Intelligence Brief. https://druglandscape.com/ci/cord-blood-infusion. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab